Kovack Advisors Inc. decreased its position in shares of The Allstate Co. (NYSE:ALL – Free Report) by 16.7% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,061 shares of the insurance provider’s stock after selling 213 shares during the period. Kovack Advisors Inc.’s holdings in Allstate were worth $201,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Oppenheimer & Co. Inc. grew its stake in shares of Allstate by 4.1% during the third quarter. Oppenheimer & Co. Inc. now owns 12,552 shares of the insurance provider’s stock valued at $2,380,000 after buying an additional 491 shares during the last quarter. Oppenheimer Asset Management Inc. boosted its holdings in Allstate by 10.9% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 63,579 shares of the insurance provider’s stock valued at $12,058,000 after acquiring an additional 6,234 shares during the period. Community Bank & Trust Waco Texas grew its position in Allstate by 12.2% in the 3rd quarter. Community Bank & Trust Waco Texas now owns 5,741 shares of the insurance provider’s stock valued at $1,089,000 after acquiring an additional 626 shares during the last quarter. Haverford Trust Co increased its stake in Allstate by 1.3% in the third quarter. Haverford Trust Co now owns 11,244 shares of the insurance provider’s stock worth $2,132,000 after purchasing an additional 149 shares during the period. Finally, Empower Advisory Group LLC bought a new stake in shares of Allstate during the third quarter worth $232,000. Hedge funds and other institutional investors own 76.47% of the company’s stock.
Insiders Place Their Bets
In other news, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the sale, the insider now directly owns 27,364 shares of the company’s stock, valued at $5,236,922.32. The trade was a 57.06 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Thomas J. Wilson sold 90,000 shares of the firm’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total value of $16,140,600.00. Following the completion of the transaction, the chief executive officer now owns 88,552 shares of the company’s stock, valued at $15,880,915.68. This trade represents a 50.41 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 143,049 shares of company stock valued at $26,106,112. Insiders own 1.80% of the company’s stock.
Allstate Price Performance
Allstate (NYSE:ALL – Get Free Report) last announced its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The company had revenue of $16.63 billion for the quarter, compared to analyst estimates of $14.57 billion. During the same period in the prior year, the company posted $0.81 EPS. The firm’s quarterly revenue was up 14.7% compared to the same quarter last year. Analysts forecast that The Allstate Co. will post 16.07 EPS for the current fiscal year.
Allstate Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Friday, November 29th will be paid a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a yield of 1.87%. The ex-dividend date is Friday, November 29th. Allstate’s dividend payout ratio (DPR) is presently 23.83%.
Analysts Set New Price Targets
A number of research analysts have recently commented on the stock. Morgan Stanley upped their price target on shares of Allstate from $220.00 to $228.00 and gave the stock an “overweight” rating in a report on Thursday, November 7th. Piper Sandler raised their target price on shares of Allstate from $188.00 to $196.00 and gave the stock an “overweight” rating in a research report on Friday, August 16th. BMO Capital Markets boosted their price target on Allstate from $205.00 to $214.00 and gave the company an “outperform” rating in a report on Friday, October 18th. UBS Group raised their price objective on Allstate from $216.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, November 4th. Finally, JPMorgan Chase & Co. upped their target price on Allstate from $205.00 to $207.00 and gave the stock an “overweight” rating in a report on Thursday, October 10th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $214.19.
Check Out Our Latest Report on Allstate
Allstate Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
See Also
- Five stocks we like better than Allstate
- Manufacturing Stocks Investing
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- What Does a Stock Split Mean?
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- What is the Australian Securities Exchange (ASX)
- Time to Load Up on Home Builders?
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.